UBS raised the firm’s price target on CACI (CACI) to $759 from $639 and keeps a Buy rating on the shares following the earnings report. The firm believes the company’s 26% increase in funded backlog, 5% organic growth with line of sight to acceleration, and continued margin expansion should “firmly put to rest any lingering debate around risk from the new administration.” UBS sees upside to CACI’s consensus estimates and valuation.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CACI:
- Strong Financial Performance and Strategic Positioning Bolster CACI International’s Market Standing
- CACI price target raised to $670 from $585 at BofA
- CACI International Reports Strong Q1 Financial Performance
- Strong Financial Performance and Strategic Positioning Drive Buy Rating for CACI International
- CACI price target raised to $670 from $600 at Stifel